Ascendis Pharma A/S

NASDAQ: ASND · Real-Time Price · USD
162.72
-0.85 (-0.52%)
At close: May 30, 2025, 3:59 PM
162.84
0.07%
After-hours: May 30, 2025, 04:44 PM EDT

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Europe Revenue 123.34M 869K 552K 6.86M 2.68M 2.65M 10.58M
Europe Revenue Growth +14092.87% +57.43% -91.95% +155.92% +1.02% -74.94% n/a
North America Revenue 233.22M 191.68M 44.16M n/a n/a n/a n/a
North America Revenue Growth +21.67% +334.09% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 101.05M 78.78M 68.13M 74.31M 66.78M 63.98M 63.61M 70.28M 66.54M 56.55M 60.67M 56.58M 47.42M 48.3M 39.28M 35.34M 37.25M 20.43M 17.52M 20.8M 17.91M 17.08M 10M 10.96M 10.44M 8.37M 6.8M 5.23M 4.66M 4.09M 2.84M 3.23M 3.33M 3.29M 2.64M 2.67M 2.91M 3.47M 1.4M 2.14M 2.4M
Selling, General, and Administrative Revenue Growth +28.26% +15.64% -8.32% +11.27% +4.39% +0.57% -9.49% +5.62% +17.66% -6.79% +7.22% +19.33% -1.83% +22.96% +11.14% -5.11% +82.35% +16.57% -15.78% +16.13% +4.91% +70.77% -8.76% +5.02% +24.64% +23.20% +30.04% +12.10% +14.10% +43.87% -12.10% -2.83% +1.19% +24.42% -1.05% -8.22% -16.20% +148.57% -34.89% -10.85% n/a
Research and Development Revenue 86.6M 79.3M 73.54M 83.48M 70.69M 90.88M 111.44M 105.02M 106.11M 108.62M 97.43M 90.38M 83.19M 65.65M 58.76M 83.31M 88.15M 75.75M 64.06M 63.58M 57.52M 50.28M 46.26M 43.83M 51.26M 37.99M 31.51M 40.23M 30.54M 28.03M 29.07M 21.88M 20.61M 19.99M 16.51M 13.28M 16.24M 12.52M 8.04M 12.64M 7.33M
Research and Development Revenue Growth +9.21% +7.82% -11.90% +18.10% -22.22% -18.45% +6.11% -1.03% -2.31% +11.48% +7.80% +8.64% +26.72% +11.73% -29.46% -5.49% +16.37% +18.25% +0.76% +10.54% +14.39% +8.69% +5.55% -14.50% +34.91% +20.58% -21.68% +31.75% +8.94% -3.55% +32.85% +6.17% +3.09% +21.08% +24.33% -18.24% +29.78% +55.70% -36.41% +72.36% n/a